Followers | 196 |
Posts | 11509 |
Boards Moderated | 0 |
Alias Born | 11/29/2007 |
Thursday, December 08, 2022 12:33:25 PM
Recent PHVS News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/25/2024 10:50:02 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/23/2024 10:51:03 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/20/2024 08:27:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/19/2024 10:45:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/19/2024 10:44:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/19/2024 08:27:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 08:46:52 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/05/2024 10:51:14 AM
- Pharvaris Provides Business Update and Expands Development Program for Deucrictibant • GlobeNewswire Inc. • 09/05/2024 10:50:00 AM
- Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024 • GlobeNewswire Inc. • 09/05/2024 10:49:00 AM
- Pharvaris Presents Data at the Bradykinin Symposium 2024 • GlobeNewswire Inc. • 09/05/2024 10:48:00 AM
- Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium • GlobeNewswire Inc. • 08/28/2024 10:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/14/2024 10:51:14 AM
- Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2024 10:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/11/2024 10:52:06 AM
- Pharvaris Announces Annual Meeting of Shareholders • GlobeNewswire Inc. • 06/11/2024 10:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/04/2024 08:05:02 PM
- Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses • GlobeNewswire Inc. • 06/04/2024 10:50:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/24/2024 09:04:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2024 09:54:50 PM
- Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses • GlobeNewswire Inc. • 05/13/2024 10:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2024 08:11:03 PM
- Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/08/2024 08:10:00 PM
- Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/10/2024 08:10:00 PM
- Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer • GlobeNewswire Inc. • 04/10/2024 08:08:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM